To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to conduct a study to assess the potential for expanding the safe and effective use of reprocessed single-use devices, and for other purposes.
Summary
HR10088 is an early-stage study bill directing the FDA to assess expanding reprocessed single-use devices. No funding, no regulatory change, and no immediate market impact. The bill is a procedural referral with no cosponsors, indicating low legislative momentum.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR10088 is a study bill with no funding or regulatory teeth.
- 2.No cosponsors and a single referral indicate low legislative momentum.
- 3.No immediate impact on medical device companies or healthcare stocks.
Market Implications
No specific market implications at this stage. The bill is a procedural study referral with no direct financial impact on any publicly traded company. Investors should focus on other legislative signals with clearer economic mechanisms.
Full Analysis
HR10088, introduced by Rep. Foushee (D-NC) on 2026-08-13, directs the Secretary of Health and Human Services, through the FDA, to conduct a study on expanding the safe and effective use of reprocessed single-use devices (SUDs). The bill was referred to the House Committee on Energy and Commerce, an early-stage action. No cosponsors have joined, and the legislative calendar remains open. The bill does not authorize any funding or mandate any regulatory changes; it is purely a study directive. As such, there is no direct money trail or immediate financial impact on any publicly traded company. The study could eventually lead to policy changes that affect the medical device industry, but that path is speculative and years away. Reprocessed SUDs, if expanded, could reduce hospital costs and potentially reduce demand for new single-use devices from manufacturers. However, at this stage, the bill is procedural and low-priority. Convergence with other signals is absent; no related bills, procurement, or presidential actions are provided. The lack of legislative momentum (single sponsor, no cosponsors, single committee referral) suggests this bill is unlikely to advance quickly. Investors should monitor for committee hearings or co-sponsor additions, but no actionable market signal exists now.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.5B Department of Homeland Security Grant
GEORGIA EMERGENCY MANAGEMENT AND HOMELAND SECURITY AGENCY: $1.6B Department of Homeland Security Grant
GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant
NORTH CAROLINA DEPARTMENT OF PUBLIC SAFETY: $2.4B Department of Homeland Security Grant
HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF: $6.0B Department of Health and Human Services Grant
DEPARTMENT OF SOCIAL SERVICES CONNECTICUT: $6.9B Department of Health and Human Services Grant
STATE OF COLORADO - DEPT OF HEALTH CARE POLICY & FINANCING: $9.2B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →